Skip to content
Methodology
All entries for: Deepcure Inc.
July 9, 2025
Deepcure Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of nuclear protein in testis (NUT) carcinoma
Disease Area:
Rare Diseases
Source
Scroll to Top
